TY - JOUR
T1 - Extracorporeal membrane oxygenation following norwood stage 1 procedures at a single institution
AU - Ugaki, Shinya
AU - Kasahara, Shingo
AU - Kotani, Yasuhiro
AU - Nakakura, Mahito
AU - Douguchi, Takuma
AU - Itoh, Hideshi
AU - Arai, Sadahiko
AU - Sano, Shunji
PY - 2010/11
Y1 - 2010/11
N2 - Extracorporeal membrane oxygenation (ECMO) is an important circulatory assist for children with refractory cardiopulmonary dysfunction, but its role and indications after a stage 1 Norwood procedure are controversial. We assessed outcomes and risk factors in patients who underwent a Norwood palliation and ECMO at our institution. We retrospectively reviewed all patients who underwent a Norwood procedure and were supported with ECMO between January 1998 and January 2010. Of the 91 children who underwent a Norwood procedure during the study period, there were 15 postoperative runs of ECMO in 12 patients. The diagnoses of the patients included five with hypoplastic left heart syndrome, five with a hypoplastic left heart syndrome variant, and two with critical aortic stenosis. A total of four patients underwent bilateral pulmonary artery banding, and two patients underwent aortic valvuloplasty before the stage 1 Norwood procedure. The mean age of the patients was 28 ± 30 days, and mean body weight was 2.6 ± 0.5 kg at the induction of ECMO. The indications for ECMO were low cardiac output in six children, circulatory collapse needing cardiopulmonary resuscitation in six children, and hypoxemia in three children. Five of the 12 patients were successfully weaned from ECMO. The significant risk factors for the inability to be weaned from ECMO were a history of circulatory collapse requiring cardiopulmonary resuscitation, and the induction of ECMO in the intensive care unit. Induction of ECMO may be considered earlier when hemodynamics are unstable in impaired patients following a stage 1 Norwood procedure to avoid circulatory collapse.
AB - Extracorporeal membrane oxygenation (ECMO) is an important circulatory assist for children with refractory cardiopulmonary dysfunction, but its role and indications after a stage 1 Norwood procedure are controversial. We assessed outcomes and risk factors in patients who underwent a Norwood palliation and ECMO at our institution. We retrospectively reviewed all patients who underwent a Norwood procedure and were supported with ECMO between January 1998 and January 2010. Of the 91 children who underwent a Norwood procedure during the study period, there were 15 postoperative runs of ECMO in 12 patients. The diagnoses of the patients included five with hypoplastic left heart syndrome, five with a hypoplastic left heart syndrome variant, and two with critical aortic stenosis. A total of four patients underwent bilateral pulmonary artery banding, and two patients underwent aortic valvuloplasty before the stage 1 Norwood procedure. The mean age of the patients was 28 ± 30 days, and mean body weight was 2.6 ± 0.5 kg at the induction of ECMO. The indications for ECMO were low cardiac output in six children, circulatory collapse needing cardiopulmonary resuscitation in six children, and hypoxemia in three children. Five of the 12 patients were successfully weaned from ECMO. The significant risk factors for the inability to be weaned from ECMO were a history of circulatory collapse requiring cardiopulmonary resuscitation, and the induction of ECMO in the intensive care unit. Induction of ECMO may be considered earlier when hemodynamics are unstable in impaired patients following a stage 1 Norwood procedure to avoid circulatory collapse.
KW - Cardiac
KW - Extracorporeal membrane oxygenation
KW - Hypoplastic heart syndrome
KW - Infant
KW - Norwood procedure
UR - http://www.scopus.com/inward/record.url?scp=78649536875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649536875&partnerID=8YFLogxK
U2 - 10.1111/j.1525-1594.2010.01141.x
DO - 10.1111/j.1525-1594.2010.01141.x
M3 - Article
C2 - 21092032
AN - SCOPUS:78649536875
SN - 0160-564X
VL - 34
SP - 898
EP - 903
JO - Artificial Organs
JF - Artificial Organs
IS - 11
ER -